Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 40
Filtrar
Más filtros

Medicinas Complementárias
Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
BMJ Open ; 12(11): e066851, 2022 11 22.
Artículo en Inglés | MEDLINE | ID: mdl-36414301

RESUMEN

OBJECTIVES: We aim to establish daily risk estimates of the relationships between grass, tree and weed pollen and asthma health outcomes. DESIGN: Time series regression analysis of exposure and health outcomes using interaction by month to determine risk estimates all year round. SETTING: Metropolitan Adelaide, South Australia. PARTICIPANTS: Health outcomes for asthma are based on 15 years of hospital admissions, 13 years emergency presentations and ambulance callouts. In adults (≥18 years), there were 10 381 hospitalisations, 26 098 emergency department (ED) presentations and 11 799 ambulance callouts and in children (0-17 years), 22 114, 39 813 and 3774, respectively. OUTCOME MEASURES: The cumulative effect of 7 day lags was calculated as the sum of the coefficients and reported as incidence rate ratio (IRR) related to an increase in 10 grains of pollen/m3. RESULTS: In relation to grass pollen, children and adults were disparate in their timing of health effects. Asthma outcomes in children were positively related to grass pollen in May, and for adults in October. Positive associations with weed pollen in children was seen from February to May across all health outcomes. For adults, weed pollen-related health outcomes were restricted to February. Adults were not affected by tree pollen, while children's asthma morbidity was associated with tree pollen in August and September. In children, IRRs ranged from 1.14 (95% CI 1.06 to 1.21) for ED presentations for tree pollen in August to 1.98 (95% CI 1.06 to 3.72) for weed pollen in February. In adults, IRRs ranged from 1.28 (95% CI 1.01 to 1.62) for weed pollen in February to 1.31 (95% CI 1.08 to 1.57) for grass pollen in October. CONCLUSION: Monthly risk assessment indicated that most pollen-related asthma health outcomes in children occur in the colder part of the year, while adults are affected in the warm season. The findings indicate a need for year-round pollen monitoring and related health campaigns to provide effective public health prevention.


Asunto(s)
Asma , Rinitis Alérgica Estacional , Niño , Adulto , Humanos , Poaceae , Árboles , Australia del Sur/epidemiología , Factores de Tiempo , Polen/efectos adversos , Asma/epidemiología , Asma/etiología , Análisis de Regresión , Evaluación de Resultado en la Atención de Salud
2.
Artículo en Inglés | MEDLINE | ID: mdl-35897462

RESUMEN

(1) Background: Limited research has suggested that cardiopulmonary health outcomes should be considered in relation to pollen exposure. This study sets out to test the relationship between pollen types (grasses, trees, weeds) and cardiovascular, lower respiratory and COPD health outcomes using 15 years (2003-2017) of data gathered in Adelaide, South Australia; (2) Methods: A time-series analysis by months was conducted using cardiopulmonary data from hospital admissions, emergency presentations and ambulance callouts in relation to daily pollen concentrations in children (0-17) for lower respiratory outcomes and for adults (18+). Incidence rate ratios (IRR) were calculated over lags from 0 to 7 days; (3) Results: IRR increases in cardiovascular outcomes in March, May, and October were related to grass pollen, while increases in July, November, and December were related to tree pollen. IRRs ranged from IRR 1.05 (95% confidence interval (CI) 1.00-1.10) to 1.25 (95% CI 1.12-1.40). COPD increases related to grass pollen occurred only in May. Pollen-related increases were observed for lower respiratory outcomes in adults and in children; (4) Conclusion: Notable increases in pollen-related associations with cardiopulmonary outcomes were not restricted to any one season. Prevention measures for pollen-related health effects should be widened to consider cardiopulmonary outcomes.


Asunto(s)
Polen , Enfermedad Pulmonar Obstructiva Crónica , Adulto , Alérgenos , Niño , Hospitalización , Humanos , Enfermedad Pulmonar Obstructiva Crónica/epidemiología , Estaciones del Año , Australia del Sur/epidemiología
3.
J Gastroenterol Hepatol ; 37(7): 1263-1274, 2022 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-35315547

RESUMEN

BACKGROUND AND AIM: Rates of antimicrobial-resistant Helicobacter pylori infection are rising globally; however, geospatial location and its interaction with risk factors for infection have not been closely examined. METHODS: Gastric biopsy specimens were collected to detect H. pylori infection at multiple centers in Adelaide, South Australia, between 1998 and 2017. The geospatial distribution of antibiotic-resistant H. pylori in the Greater Adelaide region was plotted using choropleth maps. Moran's I was used to assess geospatial correlation, and multivariate linear regression (MLR) was used to examine associations between migration status, socioeconomic status, age, gender, and rates of H. pylori positivity and antibiotic resistance. Geographically weighted regression (GWR) was used to determine the extent to which the associations varied according to geospatial location. RESULTS: Of 20 108 biopsies across 136 postcodes within the Greater Adelaide region, 1901 (9.45%) were H. pylori positive. Of these, 797 (41.9%) displayed clarithromycin, tetracycline, metronidazole, or amoxicillin resistance. In MLR, migration status was associated with the rate of H. pylori positivity (ß = 3.85% per 10% increase in a postcode's migrant population; P < 0.001). H. pylori positivity and resistance to any antibiotic were geospatially clustered (Moran's I = 0.571 and 0.280, respectively; P < 0.001 for both). In GWR, there was significant geospatial variation in the strength of the migrant association for both H. pylori positivity and antibiotic resistance. CONCLUSION: Our study demonstrates the heterogeneous geospatial distribution of H. pylori positivity and antibiotic resistance, as well as its interaction with migrant status. Geographic location and migrant status are important factors to consider for H. pylori eradication therapy.


Asunto(s)
Infecciones por Helicobacter , Helicobacter pylori , Amoxicilina/uso terapéutico , Antibacterianos/farmacología , Antibacterianos/uso terapéutico , Claritromicina , Farmacorresistencia Bacteriana , Infecciones por Helicobacter/tratamiento farmacológico , Infecciones por Helicobacter/epidemiología , Humanos , Metronidazol , Pruebas de Sensibilidad Microbiana , Australia del Sur/epidemiología
4.
PLoS One ; 16(6): e0252898, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34111173

RESUMEN

Research efforts in the initial months of the COVID-19 pandemic focused on the actual and potential impacts on societies, economies, sectors, and governments. Less attention was paid to the experiences of individuals and less still to the impact of COVID-19 on an individual's wellbeing. This research addresses this gap by utilising a holistic wellbeing framework to examine the impact of COVID-19 on the overall wellbeing of individuals in the Australian state of South Australia through an online survey. The research framework for the survey comprises six dimensions: psychological and emotional health, physical health, living standards, family and community vitality, governance, and ecological diversity and resilience. The results show that most respondents (71%) were able to maintain overall wellbeing during the pandemic. However, more than a half of the respondents could not maintain wellbeing in psychological and emotional health. Further examination of the drivers of inability to maintain overall wellbeing reveals that low-income individuals, younger respondents (aged 18-24) and women suffer disproportionate hardships. Defining poverty in terms of multi-dimensional deprivations in wellbeing enables a nuanced analysis of the unequal impacts of COVID-19 mitigation policies that can be used to improve policymaking.


Asunto(s)
COVID-19/epidemiología , Adolescente , Adulto , Anciano , Emociones , Femenino , Humanos , Masculino , Salud Mental , Persona de Mediana Edad , Pobreza , Características de la Residencia , Factores Socioeconómicos , Australia del Sur/epidemiología , Adulto Joven
5.
Int J Rheum Dis ; 24(6): 809-814, 2021 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-33881230

RESUMEN

AIM: The idiopathic inflammatory myopathies (IIM) are rare autoimmune diseases that are usually chronic and often present with skeletal muscle inflammation and weakness. We sought to examine the impact of IIM in a cohort of 50 South Australian patients on health-related quality of life (HRQOL) and work productivity (WP). We uniquely categorized patients across gender, IIM subtypes, employment status, and also whether there was extramuscular involvement from IIM. METHODS: Multiple modalities were used, as recommended by the International Myositis Assessment and Clinical Studies Group (IMACS), to assess the impact of IIM, including manual muscle strength testing (MMT-8), the Physician and Patient Global Activity Assessments (PHGAA, PTGAA), Myositis Disease Activity Assessment Tool (MDAAT), and serum creatinine kinase (CK) levels. The impacts of IIM on HRQOL and WP were analyzed using the Medical Outcomes Study 36-items Short Form (SF-36) and Work Productivity and Activity Impairment (WPAI) questionnaires, respectively. RESULTS: We found significantly lower HRQOL outcome scores in most of the SF-36 domains when compared to the most recent population norms (P ≤ .01). Physical health was predominantly affected with relative preservation of emotional health. There were also significant associations between MMT-8, PHGAA and PTGAA scores and HRQOL and WP. CONCLUSIONS: Our findings highlight the significant impact of IIM on HRQOL and WP in a well-characterized cohort of patients with IIM within Australia, and therefore the importance of a holistic approach to the management of these patients.


Asunto(s)
Absentismo , Miositis/psicología , Presentismo , Calidad de Vida/psicología , Trabajo , Adulto , Anciano , Estudios de Cohortes , Eficiencia , Femenino , Humanos , Masculino , Persona de Mediana Edad , Músculo Esquelético/patología , Miositis/epidemiología , Perfil de Impacto de Enfermedad , Australia del Sur/epidemiología
6.
Eur J Gastroenterol Hepatol ; 32(10): 1381-1389, 2020 10.
Artículo en Inglés | MEDLINE | ID: mdl-31895911

RESUMEN

AIM: The objective was to study the long-term (lifetime) cost effectiveness of four different hepatitis C virus (HCV) treatment models of care (MOC) with directly acting antiviral drugs. METHODS: A cohort Markov model-based probabilistic cost-effectiveness analysis (CEA) was undertaken extrapolating to up to 30 years from cost and outcome data collected from a primary study involving a real-life Australian cohort. In this study, noncirrhotic patients treated for HCV from 1 March 2016 to 28 February 2017 at four major public hospitals and liaising sites in South Australia were studied retrospectively. The MOC were classified depending on the person providing patient workup, treatment and monitoring into MOC1 (specialist), MOC2 (mixed specialist and hepatitis nurse), MOC3 (hepatitis nurse) and MOC4 (general practitioner, GP). Incremental costs were estimated from the Medicare perspective. Incremental outcomes were estimated based on the quality-adjusted life years (QALY) gained by achieving a sustained virological response. A cost-effectiveness threshold of Australian dollar 50 000 per QALY gained, the implicit criterion used for assessing the cost-effectiveness of new pharmaceuticals and medical services in Australia was assumed. Net monetary benefit (NMB) estimates based on this threshold were calculated. RESULTS: A total of 1373 patients, 64% males, mean age 50 (SD ±11) years, were studied. In the CEA, MOC4 and MOC2 clearly dominated MOC1 over 30 years with lower costs and higher QALYs. Similarly, NMB was the highest in MOC4, followed by MOC2. CONCLUSION: Decentralized care using GP and mixed consultant nurse models were cost-effective ways of promoting HCV treatment uptake in the setting of unrestricted access to new antivirals.


Asunto(s)
Hepatitis C Crónica , Hepatitis C , Anciano , Antivirales/uso terapéutico , Australia/epidemiología , Análisis Costo-Beneficio , Femenino , Hepacivirus , Hepatitis C/tratamiento farmacológico , Hepatitis C Crónica/diagnóstico , Hepatitis C Crónica/tratamiento farmacológico , Hepatitis C Crónica/epidemiología , Humanos , Masculino , Cadenas de Markov , Persona de Mediana Edad , Programas Nacionales de Salud , Años de Vida Ajustados por Calidad de Vida , Estudios Retrospectivos , Australia del Sur/epidemiología
7.
Am J Epidemiol ; 188(2): 332-338, 2019 02 01.
Artículo en Inglés | MEDLINE | ID: mdl-30452542

RESUMEN

There are limited and inconsistent data suggesting that mild iodine deficiency in pregnancy might be associated with poorer developmental outcomes in children. Between 2011 and 2015, we conducted a prospective cohort study in Australia examining the relationship between maternal iodine intake in pregnancy and childhood neurodevelopment, assessed using Bayley Scales of Infant and Toddler Development, Third Edition (Bayley-III), in 699 children at 18 months. Maternal iodine intake and urinary iodine concentration (UIC) were assessed at study entry (<20 weeks' gestation) and at 28 weeks' gestation. Maternal iodine intake in the lowest (<220 µg/day) or highest (≥391 µg/day) quartile was associated with lower cognitive, language, and motor scores (mean differences ranged from 2.4 (95% confidence interval (CI): 0.01, 4.8) to 7.0 (95% CI: 2.8, 11.1) points lower) and higher odds (odds ratios ranged from 2.7 (95% CI: 1.3, 5.6) to 2.8 (95% CI: 1.3, 5.7)) of cognitive developmental delay (Bayley-III score <1 SD) compared with mothers with an iodine intake in the middle quartiles. There was no association between UIC in pregnancy and Bayley-III outcomes regardless of whether UIC and the outcomes were analyzed as continuous or categorical variables. Both low and high iodine intakes in pregnancy were associated with poorer childhood neurodevelopment in this iodine-sufficient population.


Asunto(s)
Desarrollo Infantil/efectos de los fármacos , Discapacidades del Desarrollo/epidemiología , Suplementos Dietéticos , Yodo/administración & dosificación , Adulto , Trastornos del Conocimiento/epidemiología , Femenino , Humanos , Lactante , Yodo/deficiencia , Yodo/orina , Lenguaje , Masculino , Destreza Motora , Embarazo , Estudios Prospectivos , Australia del Sur/epidemiología
8.
Vaccine ; 36(12): 1621-1626, 2018 03 14.
Artículo en Inglés | MEDLINE | ID: mdl-29449097

RESUMEN

To address the phenomenon of vaccine hesitancy and rejection, researchers increasingly recognise the need to engage with the social context of parents' decision-making. This study examines how vaccine rejecting parents socially construct the vaccinating mainstream in opposition to themselves. We analyse qualitative data from interviews with parents in Adelaide, South Australia. Applying insights from Social Identity Theory (SIT), we show how these parents bolster their own sense of identity and self-belief by employing a discourse that casts vaccinators as an Unhealthy Other. We demonstrate how the parents identify vaccination as a marker of parental conformity to the 'toxic practices of mass industrial society', linking it to other ways in which membership of the consumerist mainstream requires individuals to 'neglect their health.' This is explored through themes of appearance, diet, (over) consumption of pharmaceuticals, inadequate parenting values and wilful or misguided ignorance. This construction of the Unhealthy Other elevates the self-concept of vaccine hesitant and rejecting parents, who see themselves as part of an enlightened, but constantly besieged, group of healthy and virtuous parents. It is common for the vaccinating mainstream to present vaccine hesitant and rejecting parents as a group subject to epistemic closure, groupthink, confirmation bias and over-confidence in their own expertise. However, vaccine hesitant and rejecting parents also see mainstream society as a group-a much larger one-subject to the same problems. We suggest the need to mitigate the 'groupness' of vaccination and non-vaccination by extending the practice of vaccination to recognisable practitioners of holistic health.


Asunto(s)
Responsabilidad Parental , Padres , Aceptación de la Atención de Salud , Vacunación , Toma de Decisiones , Femenino , Humanos , Masculino , Vigilancia en Salud Pública , Australia del Sur/epidemiología , Encuestas y Cuestionarios , Vacunación/psicología
9.
Am J Phys Anthropol ; 163(3): 519-530, 2017 07.
Artículo en Inglés | MEDLINE | ID: mdl-28374451

RESUMEN

OBJECTIVES: In many hunter-gatherer populations, the teeth are used as a third hand or a tool. Much attention has been paid to wear and its relationship to gendered division of labor, but age is also a significant organizing factor in many societies. In this article, I analyze whether the pattern of wear at Roonka, Australia, reflects the age-graded acquisition of tasks. MATERIALS AND METHODS: The remains analyzed come from Roonka and date from c6000 BP to 150 BP. In total 126 adults and juveniles were analyzed. Wear gradients were calculated for each tooth relative to wear on the first molar. Data were compared using nonparametric statistics and cluster analysis to assess the degree of patterning within the sample. RESULTS: Dental wear proceeded rapidly. There is no evidence of sex differences in the pattern of wear. Age differences do occur. While disproportionate anterior wear occurs among juveniles and young adults, by middle adulthood the pattern is less variable and involves the premolars. Old adults have a much flatter pattern of wear. DISCUSSION: The pattern of wear is consistent with ethnographic observations, which suggest a degree of latitude in the activities of juveniles and young adults. By middle age variability between individuals declines reflecting shared tasks and more intensive use of the teeth. The pattern of wear amongst old adults, however, is much flatter presumably due to changes in occlusion. While dental wear is informative about the organization of labor there is a need to take into account both patterns of activity and occlusion.


Asunto(s)
Desgaste de los Dientes , Adolescente , Adulto , Antropología Física , Niño , Análisis por Conglomerados , Femenino , Historia Antigua , Humanos , Masculino , Persona de Mediana Edad , Factores Sexuales , Australia del Sur/epidemiología , Estadísticas no Paramétricas , Diente/patología , Desgaste de los Dientes/epidemiología , Desgaste de los Dientes/historia , Desgaste de los Dientes/patología , Adulto Joven
10.
Br J Nutr ; 116(11): 1901-1911, 2016 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27923410

RESUMEN

Se and green tea have been shown in epidemiological, observational and preclinical studies to be inversely related to the risk of developing colorectal cancer (CRC). However, there are limited studies to evaluate their regulatory effects on genes/proteins that relate to CRC oncogenesis in human subjects, such as selenoproteins, WNT signalling pathway, inflammation and methylation. This study examined the effects of supplementation of Se using Brazil nuts and green tea extract (GTE) capsules, alone and in combination, on targeted biomarkers. In total, thirty-two volunteers (>50 years of age) with plasma Se≤1·36 µmol/l were randomised to one of three treatment groups: nine to Se (approximately 48 µg/d) as six Brazil nuts, eleven to four GTE capsules (800 mg (-)-epigallocatechin-3-gallate) and twelve to a combination of Brazil nuts and GTE. Blood and rectal biopsies were obtained before and after each intervention. Plasma Se levels, rectal selenoprotein P (SePP) and ß-catenin mRNA increased significantly in subjects consuming Brazil nuts alone or in combination, whereas rectal DNA methyltransferase (DNMT1) and NF-κB mRNA were reduced significantly in subjects consuming GTE alone or in combination. None of the interventions significantly affected rectal acetylated histone H3 or Ki-67 expression at the protein level or plasma C-reactive protein. Effects of the combination of Brazil nuts and GTE did not differ from what would be expected from either agent alone. In conclusion, supplementation of Brazil nuts and/or GTE regulates targeted biomarkers related to CRC oncogenesis, specifically genes associated with selenoproteins (SePP), WNT signalling (ß-catenin), inflammation (NF-κB) and methylation (DNMT1). Their combination does not appear to provide additional effects compared with either agent alone.


Asunto(s)
Anticarcinógenos/uso terapéutico , Bertholletia , Camellia sinensis/química , Neoplasias Colorrectales/prevención & control , Suplementos Dietéticos , Nueces , Extractos Vegetales/uso terapéutico , Anciano , Bertholletia/efectos adversos , Bertholletia/química , Biomarcadores de Tumor/sangre , Biomarcadores de Tumor/metabolismo , Neoplasias Colorrectales/epidemiología , Neoplasias Colorrectales/metabolismo , Neoplasias Colorrectales/patología , Suplementos Dietéticos/efectos adversos , Estudios de Factibilidad , Femenino , Manipulación de Alimentos , Alimentos Funcionales/efectos adversos , Humanos , Mucosa Intestinal/metabolismo , Mucosa Intestinal/patología , Masculino , Persona de Mediana Edad , Nueces/efectos adversos , Nueces/química , Extractos Vegetales/efectos adversos , Extractos Vegetales/química , Hojas de la Planta/química , Recto/metabolismo , Recto/patología , Riesgo , Selenio/administración & dosificación , Selenio/efectos adversos , Selenio/sangre , Selenio/uso terapéutico , Australia del Sur/epidemiología
11.
BMJ Open ; 6(12): e012505, 2016 12 23.
Artículo en Inglés | MEDLINE | ID: mdl-28011808

RESUMEN

INTRODUCTION: In Australia, Aboriginal and Torres Strait Islander People carry a greater burden of cancer-related mortality than non-Aboriginal Australians. The Cancer Data and Aboriginal Disparities Project aims to develop and test an integrated, comprehensive cancer monitoring and surveillance system capable of incorporating epidemiological and narrative data to address disparities and advocate for clinical system change. METHODS AND ANALYSIS: The Advanced Cancer Data System will integrate routinely collected unit record data from the South Australian Population Cancer Registry and a range of other data sources for a retrospective cohort of indigenous people with cancers diagnosed from 1990 to 2010. A randomly drawn non-Aboriginal cohort will be matched by primary cancer site, sex, age and year at diagnosis. Cross-tabulations and regression analyses will examine the extent to which demographic attributes, cancer stage and survival vary between the cohorts. Narratives from Aboriginal people with cancer, their families, carers and service providers will be collected and analysed using patient pathway mapping and thematic analysis. Statements from the narratives will structure both a concept mapping process of rating, sorting and prioritising issues, focusing on issues of importance and feasibility, and the development of a real-time Aboriginal Cancer Measure of Experience for ongoing linkage with epidemiological data in the Advanced Cancer Data System. Aboriginal Community engagement underpins this Project. ETHICS AND DISSEMINATION: The research has been approved by relevant local and national ethics committees. Findings will be disseminated in local and international peer-reviewed journals and conference presentations. In addition, the research will provide data for knowledge translation activities across the partner organisations and feed directly into the Statewide Cancer Control Plan. It will provide a mechanism for monitoring and evaluating the implementation of the recommendations in these documents.


Asunto(s)
Conjuntos de Datos como Asunto , Disparidades en el Estado de Salud , Nativos de Hawái y Otras Islas del Pacífico , Neoplasias/epidemiología , Vigilancia de la Población/métodos , Femenino , Servicios de Salud del Indígena , Humanos , Masculino , Proyectos de Investigación , Estudios Retrospectivos , Australia del Sur/epidemiología
12.
Clin Exp Allergy ; 46(11): 1416-1430, 2016 11.
Artículo en Inglés | MEDLINE | ID: mdl-27513706

RESUMEN

BACKGROUND: Air pollution can have adverse health effects on asthma sufferers, but the effects vary with geographic, environmental and population characteristics. There has been no long time-series study in Australia to quantify the effects of environmental factors including pollen on asthma hospitalizations. OBJECTIVES: This study aimed to assess the seasonal impact of air pollutants and aeroallergens on the risk of asthma hospital admissions for adults and children in Adelaide, South Australia. METHODS: Data on hospital admissions, meteorological conditions, air quality and pollen counts for the period 2003-2013 were sourced. Time-series analysis and case-crossover analysis were used to assess the short-term effects of air pollution on asthma hospitalizations. For the time-series analysis, generalized log-linear quasi-Poisson and negative binomial regressions were used to assess the relationships, controlling for seasonality and long-term trends using flexible spline functions. For the case-crossover analysis, conditional logistic regression was used to compute the effect estimates with time-stratified referent selection strategies. RESULTS: A total of 36,024 asthma admissions were considered. Findings indicated that the largest effects on asthma admissions related to PM2.5 , NO2 , PM10 and pollen were found in the cool season for children (0-17 years), with the 5-day cumulative effects of 30.2% (95% CI: 13.4-49.6%), 12.5% (95% CI: 6.6-18.7%), 8.3% (95% CI: 2.5-14.4%) and 4.2% (95% CI: 2.2-6.1%) increases in risk of asthma hospital admissions per 10 unit increments, respectively. The largest effect for ozone was found in the warm season for children with the 5-day cumulative effect of an 11.7% (95% CI: 5.8-17.9%) increase in risk of asthma hospital admissions per 10 ppb increment in ozone level. CONCLUSION: Findings suggest that children are more vulnerable and the associations between exposure to air pollutants and asthma hospitalizations tended to be stronger in the cool season compared to the warm season, with the exception of ozone. This study has important public health implications and provides valuable evidence for the development of policies for asthma management.


Asunto(s)
Contaminación del Aire/efectos adversos , Asma/epidemiología , Asma/etiología , Hospitalización , Adolescente , Adulto , Contaminantes Atmosféricos/efectos adversos , Asma/historia , Niño , Preescolar , Exposición a Riesgos Ambientales/efectos adversos , Femenino , Historia del Siglo XXI , Hospitalización/estadística & datos numéricos , Humanos , Lactante , Recién Nacido , Masculino , Oportunidad Relativa , Material Particulado/efectos adversos , Polen/inmunología , Estaciones del Año , Australia del Sur/epidemiología , Tiempo (Meteorología) , Adulto Joven
13.
BMJ Open ; 6(2): e010286, 2016 Feb 23.
Artículo en Inglés | MEDLINE | ID: mdl-26908527

RESUMEN

OBJECTIVES: Indigenous women continue to experience rates of stillbirth, preterm birth and low birth weight, two to three times higher than other women in high-income countries. The reasons for disparities are complex and multifactorial. We aimed to assess the extent to which adverse birth outcomes are associated with maternal cannabis use and exposure to stressful events and social health issues during pregnancy. DESIGN/SETTING: Cross-sectional, population-based survey of women giving birth to Aboriginal babies in South Australia, July 2011-June 2013. Data include: maternal cannabis use, exposure to stressful events/social health issues, infant birth weight and gestation. PARTICIPANTS: 344 eligible women with a mean age of 25 years (range 15-43 years), enrolled in the study. Participants were representative in relation to maternal age, infant birth weight and gestation. RESULTS: 1 in 5 women (20.5%) used cannabis during pregnancy, and 52% smoked cigarettes. Compared with mothers not using cannabis or cigarettes, mothers using cannabis had babies on average 565 g lighter (95% CI -762 to -367), and were more likely to have infants with a low birth weight (OR=6.5, 95% CI 3.0 to 14.3), and small for gestational age (OR=3.8, 95% CI 1.9 to 7.6). Controlling for education and other social characteristics, including stressful events/social health issues did not alter the conclusion that mothers using cannabis experience a higher risk of negative birth outcomes (adjusted OR for odds of low birth weight 3.9, 95% CI 1.4 to 11.2). CONCLUSIONS: The findings provide a compelling case for stronger efforts to address the clustering of risk for adverse outcomes in Aboriginal and Torres Strait Islander communities, and point to the need for antenatal care to address broader social determinants of adverse perinatal outcomes. Integrated responses--collaboratively developed with Aboriginal communities and organisations--that focus on constellations of risk factors, and a holistic approach to addressing social determinants of adverse birth outcomes, are required.


Asunto(s)
Recién Nacido de Bajo Peso , Fumar Marihuana/efectos adversos , Nativos de Hawái y Otras Islas del Pacífico/estadística & datos numéricos , Nacimiento Prematuro/epidemiología , Efectos Tardíos de la Exposición Prenatal/epidemiología , Mortinato/epidemiología , Adolescente , Adulto , Cannabis/efectos adversos , Estudios Transversales , Femenino , Humanos , Recién Nacido , Embarazo , Resultado del Embarazo , Factores de Riesgo , Fumar/efectos adversos , Australia del Sur/epidemiología , Adulto Joven
14.
J Paediatr Child Health ; 51(6): 614-9, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25394218

RESUMEN

AIM: To assess vitamin D status and its predictors in a representative population sample of pre-school children in Adelaide (latitude of 35°S). METHODS: Cross-sectional survey of children aged between 1 and 5 years from areas of low, medium and high socio-economic status as identified from the 2001 Census data, Australian Bureau of Statistics. Children were recruited between September 2005 and July 2007 using a door knocking protocol based on a stratified sampling method to obtain a representative sample of this age group. Serum 25-hydroxyvitamin D (25(OH)D) was determined using a radio-immunoassay kit. Vitamin D deficiency was defined as serum 25(OH)D) <30 nmol/L and insufficiency defined as serum 25(OH)D ≥30 and <50 nmol/L according to the Institute of Medicine. RESULTS: Fifty-two per cent of eligible children took part in the study. Mean (standard deviation) serum 25(OH)D was 73 (26) nmol/L (n = 221). The prevalence of vitamin D deficiency and insufficiency was 4% and 16%, respectively, with the prevalence being higher in winter (8% and 22%, respectively). Season of the year of blood collection and mother being born in Australia were significant predictors of serum 25(OH)D concentration, but age, sex, socio-economic status, BMI category or dietary supplement use were not related to vitamin D status. CONCLUSIONS: Vitamin D status of this representative sample of pre-school children in Australia is adequate, and the prevalence of vitamin D deficiency is low based on the Institute of Medicine criteria.


Asunto(s)
Deficiencia de Vitamina D/epidemiología , Vitamina D/análogos & derivados , Preescolar , Estudios Transversales , Femenino , Humanos , Lactante , Masculino , Prevalencia , Radioinmunoensayo , Factores de Riesgo , Australia del Sur/epidemiología , Vitamina D/sangre
15.
BMC Public Health ; 14: 1001, 2014 Sep 26.
Artículo en Inglés | MEDLINE | ID: mdl-25256413

RESUMEN

BACKGROUND: Levels of vitamin D in the population have come under increasing scrutiny, however there are only a few studies in Australia which measure levels in the general population. The aim of this study was to measure the levels of vitamin D within a large population cohort and examine the association with seasons and selected demographic and health risk factors. METHODS: A longitudinal cohort study of 2413 participants in the northwest suburbs of Adelaide, South Australia conducted between 2008 and 2010 was used to examine serum levels of 25-hydroxy vitamin D (25(OH)D) in relation to demographic characteristics (age, sex, income, education and country of birth), seasons, the use of vitamin D supplements and selected health risk factors (physical activity, body mass index and smoking). Both unadjusted and adjusted mean levels of serum 25(OH)D were examined, as were the factors associated with the unadjusted and adjusted prevalence of serum 25(OH)D levels below 50 and 75 nmol/L. RESULTS: Overall, the mean level of serum 25(OH)D was 69.2 nmol/L with 22.7% of the population having a serum 25(OH)D level below 50 nmol/L, the level which is generally recognised as vitamin D deficiency. There were significantly higher levels of 25(OH)D among males compared to females (t = 4.65, p < 0.001). Higher levels of 25(OH)D were also measured in summer and autumn compared with winter and spring. Generally, mean levels of 25(OH)D were lower in those classified as obese. Smokers and those undertaking no or less than 150 minutes/week of physical activity also had lower levels of serum vitamin D. Obesity (as classified by body mass index), season and undertaking an insufficient level of physical activity to obtain a health benefit were significantly associated with the prevalence of vitamin D deficiency. CONCLUSIONS: Vitamin D deficiency is prevalent in South Australia, affecting almost one quarter of the population and levels are related to activity, obesity and season even when adjusted for confounding factors. Improved methods of addressing vitamin D levels in population are required.


Asunto(s)
Encuestas Epidemiológicas/estadística & datos numéricos , Deficiencia de Vitamina D/sangre , Deficiencia de Vitamina D/epidemiología , Vitamina D/análogos & derivados , Adulto , Factores de Edad , Anciano , Anciano de 80 o más Años , Índice de Masa Corporal , Estudios de Cohortes , Suplementos Dietéticos/estadística & datos numéricos , Femenino , Humanos , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Obesidad/sangre , Obesidad/epidemiología , Prevalencia , Factores de Riesgo , Estaciones del Año , Factores Sexuales , Fumar/sangre , Fumar/epidemiología , Factores Socioeconómicos , Australia del Sur/epidemiología , Vitamina D/sangre , Adulto Joven
16.
Emerg Infect Dis ; 19(9)2013.
Artículo en Inglés | MEDLINE | ID: mdl-23968779

RESUMEN

An outbreak of skin abscesses occurred in Adelaide, Australia, in association with biomesotherapy, an alternative therapy practice. Mycobacterium chelonae was identified in 8 patient and 3 environmental samples. Our findings show M. chelonae infection can be associated with alternative therapies when infection-control breaches occur. Tighter regulations of alternative therapy practices are needed.


Asunto(s)
Absceso/epidemiología , Terapias Complementarias/efectos adversos , Infecciones por Mycobacterium no Tuberculosas/epidemiología , Mycobacterium chelonae , Absceso/microbiología , Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Infecciones por Mycobacterium no Tuberculosas/microbiología , Enfermedades Cutáneas Bacterianas/epidemiología , Enfermedades Cutáneas Bacterianas/microbiología , Australia del Sur/epidemiología
17.
Nutr J ; 12: 32, 2013 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-23497409

RESUMEN

Mild iodine deficiency during pregnancy can have significant effects on fetal development and future cognitive function. The purpose of this study was to characterise the iodine status of South Australian women during pregnancy and relate it to the use of iodine-containing multivitamins. The impact of fortification of bread with iodized salt was also assessed. Women (n = 196) were recruited prospectively at the beginning of pregnancy and urine collected at 12, 18, 30, 36 weeks gestation and 6 months postpartum. The use of a multivitamin supplement was recorded at each visit. Spot urinary iodine concentrations (UIC) were assessed. Median UICs were within the mildly deficient range in women not taking supplements (<90 µg/L). Among the women taking iodine-containing multivitamins UICs were within WHO recommendations (150-249 µg/L) for sufficiency and showed an increasing trend through gestation. The fortification of bread with iodized salt increased the median UIC from 68 µg/L to 84 µg/L (p = .011) which was still in the deficient range. Pregnant women in this region of Australia were unlikely to reach recommended iodine levels without an iodine supplement, even after the mandatory iodine supplementation of bread was instituted in October 2009.


Asunto(s)
Pan , Suplementos Dietéticos , Alimentos Fortificados , Yodo/administración & dosificación , Yodo/orina , Desnutrición/epidemiología , Adolescente , Adulto , Australia , Índice de Masa Corporal , Femenino , Humanos , Yodo/deficiencia , Desnutrición/tratamiento farmacológico , Estado Nutricional , Embarazo , Estudios Prospectivos , Cloruro de Sodio Dietético/administración & dosificación , Australia del Sur/epidemiología , Enfermedades de la Tiroides/tratamiento farmacológico , Enfermedades de la Tiroides/epidemiología , Adulto Joven
18.
BMC Health Serv Res ; 12: 266, 2012 Aug 21.
Artículo en Inglés | MEDLINE | ID: mdl-22905669

RESUMEN

BACKGROUND: Methods for the cost-effectiveness analysis of health technologies are now well established, but such methods may also have a useful role in the context of evaluating the effects of variation in applied clinical practice. This study illustrates a general methodology for the comparative analysis of applied clinical practice at alternative institutions--risk adjusted cost-effectiveness (RAC-E) analysis--with an application that compares acute hospital services for stroke patients admitted to the main public hospitals in South Australia. METHODS: Using linked, routinely collected data on all South Australian hospital separations from July 2001 to June 2008, an analysis of the RAC-E of services provided at four metropolitan hospitals was undertaken using a decision analytic framework. Observed (plus extrapolated) and expected lifetime costs and survival were compared across patient populations, from which the relative cost-effectiveness of services provided at the different hospitals was estimated. RESULTS: Unadjusted results showed that at one hospital patients incurred fewer costs and gained more life years than at the other hospitals (i.e. it was the dominant hospital). After risk adjustment, the cost minimizing hospital incurred the lowest costs, but with fewer life-years gained than one other hospital. The mean incremental cost per life-year gained of services provided at the most effective hospital was under $20,000, with an associated 65% probability of being cost-effective at a $50,000 per life year monetary threshold. CONCLUSIONS: RAC-E analyses can be used to identify important variation in the costs and outcomes associated with clinical practice at alternative institutions. Such data provides an impetus for further investigation to identify specific areas of variation, which may then inform the dissemination of best practice service delivery and organisation.


Asunto(s)
Pautas de la Práctica en Medicina/economía , Accidente Cerebrovascular/terapia , Anciano , Análisis Costo-Beneficio , Femenino , Hospitales/estadística & datos numéricos , Humanos , Masculino , Evaluación de Procesos y Resultados en Atención de Salud , Pautas de la Práctica en Medicina/estadística & datos numéricos , Años de Vida Ajustados por Calidad de Vida , Ajuste de Riesgo , Índice de Severidad de la Enfermedad , Australia del Sur/epidemiología , Accidente Cerebrovascular/economía , Accidente Cerebrovascular/mortalidad , Análisis de Supervivencia
19.
Sex Health ; 9(3): 220-6, 2012 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-22697138

RESUMEN

BACKGROUND: As financial constraints can be a barrier to accessing HIV antiretroviral therapy (ART), we argue for the removal of copayment requirements from HIV medications in South Australia. METHODS: Using a simple mathematical model informed by available behavioural and biological data and reflecting the HIV epidemiology in South Australia, we calculated the expected number of new HIV transmissions caused by persons who are not currently on ART compared with transmissions for people on ART. The extra financial investment required to cover the copayments to prevent an HIV infection was compared with the treatment costs saved due to averting HIV infections. RESULTS: It was estimated that one HIV infection is prevented per year for every 31.4 persons (median, 24.0-42.7 interquartile range (IQR)) who receive treatment. By considering the incremental change in costs and outcomes of a change in program from the current status quo, it would cost the health sector $17860 per infection averted (median, $13651-24287 IQR) if ART is provided as a three-dose, three-drug combination without requirements for user-pay copayments. CONCLUSIONS: The costs of removing copayment fees for ART are less than the costs of treating extra HIV infections that would result under current conditions. Removing the copayment requirement for HIV medication would be cost-effective from a governmental perspective.


Asunto(s)
Atención Ambulatoria/economía , Terapia Antirretroviral Altamente Activa/economía , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/economía , Costos de la Atención en Salud/estadística & datos numéricos , Accesibilidad a los Servicios de Salud/economía , Ahorro de Costo , Análisis Costo-Beneficio , Femenino , Humanos , Masculino , Tamizaje Masivo/economía , Modelos Estadísticos , Programas Nacionales de Salud/economía , Australia del Sur/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA